All Curated Mutation Sites in HBV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HBV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Show All

BCP

Core Promoter

Core Upstream Regulatory Sequence

Keyword: Carcinoma, Hepatocellular-18216102

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	18216102	A1499G	P	P	Carcinoma, Hepatocellular	G C L	View
2	18216102	G1613A	P	P	Carcinoma, Hepatocellular	G C L	View
3	18216102	G1899A	PreC	C	Carcinoma, Hepatocellular	G C L	View
4	18216102	T2170C	C	C	Carcinoma, Hepatocellular	G C L	View
5	18216102	T2441C	C	C	Carcinoma, Hepatocellular	G C L	View
6	18216102	T31C	P	P	Carcinoma, Hepatocellular	G C L	View
7	18216102	T53C	PreS	S	Carcinoma, Hepatocellular	G C L	View
8	18216102	A1762T	X	X	Carcinoma, Hepatocellular	G C L	View
9	18216102	A2525C	P	P	Carcinoma, Hepatocellular	G C L	View
10	18216102	C1165T	P	P	Carcinoma, Hepatocellular	G C L	View
11	18216102	G1764A	X	X	Carcinoma, Hepatocellular	G C L	View
12	18216102	T2170G	C	C	Carcinoma, Hepatocellular	G C L	View
13	18216102	T2525C	P	P	Carcinoma, Hepatocellular	G C L	View
14	18216102	T2712A	P	P	Carcinoma, Hepatocellular	G C L	View
15	18216102	T2712C	P	P	Carcinoma, Hepatocellular	G C L	View
16	18216102	T2712G	P	P	Carcinoma, Hepatocellular	G C L	View
17	18216102	F141L	PreS	S	Carcinoma, Hepatocellular	G C L	View
18	18216102	G29D	PreC	C	Carcinoma, Hepatocellular	G C L	View
19	18216102	H113R	P	P	Carcinoma, Hepatocellular	G C L	View
20	18216102	K130M	X	X	Carcinoma, Hepatocellular	G C L	View
21	18216102	K73N	P	P	Carcinoma, Hepatocellular	G C L	View
22	18216102	N73N	P	P	Carcinoma, Hepatocellular	G C L	View
23	18216102	N90K	C	C	Carcinoma, Hepatocellular	G C L	View
24	18216102	N90N	C	C	Carcinoma, Hepatocellular	G C L	View
25	18216102	P2S	P	P	Carcinoma, Hepatocellular	G C L	View
26	18216102	R151K	P	P	Carcinoma, Hepatocellular	G C L	View
27	18216102	S137P	P	P	Carcinoma, Hepatocellular	G C L	View
28	18216102	S181P	C	C	Carcinoma, Hepatocellular	G C L	View
29	18216102	V131I	X	X	Carcinoma, Hepatocellular	G C L	View
30	18216102	Y136D	P	P	Carcinoma, Hepatocellular	G C L	View
31	18216102	Y136H	P	P	Carcinoma, Hepatocellular	G C L	View
32	18216102	Y136N	P	P	Carcinoma, Hepatocellular	G C L	View

Contents
Description

The table shows all curated mutation sites of HBV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.